Davidson Capital Management Inc. Vertex Pharmaceuticals Inc Transaction History
Davidson Capital Management Inc.
- $324 Million
- Q2 2024
A detailed history of Davidson Capital Management Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Davidson Capital Management Inc. holds 7,205 shares of VRTX stock, worth $3.23 Million. This represents 1.04% of its overall portfolio holdings.
Number of Shares
7,205
Previous 5,822
23.75%
Holding current value
$3.23 Million
Previous $2.43 Million
38.8%
% of portfolio
1.04%
Previous 0.79%
Shares
18 transactions
Others Institutions Holding VRTX
# of Institutions
1,706Shares Held
225MCall Options Held
1.2MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.3 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.56 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.26 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$3.83 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $115B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...